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Abstract
Background: Staphylococcus aureus, a leading cause of chronic or acute infections, is traditionally
considered an extracellular pathogen despite repeated reports of S. aureus internalization by a
variety of non-myeloid cells in vitro. This property potentially contributes to bacterial persistence,
protection from antibiotics and evasion of immune defenses. Mechanisms contributing to
internalization have been partly elucidated, but bacterial processes triggered intracellularly are
largely unknown.
Results:  We have developed an in vitro model using human lung epithelial cells that shows
intracellular bacterial persistence for up to 2 weeks. Using an original approach we successfully
collected and amplified low amounts of bacterial RNA recovered from infected eukaryotic cells.
Transcriptomic analysis using an oligoarray covering the whole S. aureus genome was performed at
two post-internalization times and compared to gene expression of non-internalized bacteria. No
signs of cellular death were observed after prolonged internalization of Staphylococcusaureus 6850
in epithelial cells. Following internalization, extensive alterations of bacterial gene expression were
observed. Whereas major metabolic pathways including cell division, nutrient transport and
regulatory processes were drastically down-regulated, numerous genes involved in iron scavenging
and virulence were up-regulated. This initial adaptation was followed by a transcriptional increase
in several metabolic functions. However, expression of several toxin genes known to affect host
cell integrity appeared strictly limited.
Conclusion: These molecular insights correlated with phenotypic observations and demonstrated
that  S. aureus modulates gene expression at early times post infection to promote survival.
Staphylococcusaureus appears adapted to intracellular survival in non-phagocytic cells.
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Background
Staphylococcus aureus is a versatile pathogenic bacterium
capable of rapidly developing or acquiring multiple anti-
biotic resistances, and is now recognized as a worldwide
health problem [1]. S. aureus is responsible for a wide
spectrum of human and animal diseases, ranging from
benign skin infections to severe diseases, such as arthritis,
osteomyelitis, endocarditis or fatal sepsis [2]. Acute infec-
tions are related to the organisms' capacity to secrete a
plethora of exotoxins [3,4] and catabolic enzymes [2,5],
as documented previously in different experimental mod-
els of acute infections [6-8]. S. aureus is also responsible
for chronic diseases such as osteomyelitis [9], rhinosinusi-
tis [10], or otitis [11]. These infections are difficult to erad-
icate and often relapse even after prolonged and adapted
antibiotic therapy [12,13], suggesting that S. aureus has
developed specific strategies for intracellular persistence.
In addition, anti-infective agents commonly used for the
treatment of S. aureus infections could enhance selection
of invasive intracellular strains [14].
In contrast to other persistent human pathogens, S. aureus
is not traditionally considered as an intracellular patho-
gen [15]. Nevertheless, substantial evidence strongly sup-
ports that S. aureus can be internalized and survive in a
variety of non-professional phagocytic cells in vitro [2,16-
18] and in vivo [19,20]. The endocytic uptake of S. aureus
by non-myeloid cells involves active cellular processes
that depend upon F-actin polymerization and is similar in
many respects to that observed in professional phagocytes
[17]. Whereas entero-invasive pathogens utilize secretion
systems to actively induce their own uptake by the host
cell, internalization of S. aureus by non-professional
phagocytes shows similar efficiency in vitro with live or
killed bacteria [17,21]. The mechanism relies on an inter-
action between fibronectin binding protein and host-cell
α5β1 integrins [17,22,23]. The role of other bacterial sur-
face proteins like clumping-factor A or host cell Src kinase
also appears important in the mediation of S. aureus
uptake and intracellular persistence [18,24]. After inter-
nalization, the behavior of the bacterium varies according
to cell-line or bacterial strain. For example, some authors
reported active intracellular bacterial replication within
vacuoles [25] or rapid bacterial escape from vacuole and
induction of cellular apoptosis [26-28], while others
described persistence for several days before induction of
escape processes [29]. The production of α-toxin appears
correlated with the induction of apoptosis [27,30,31].
Regulation of α-toxin expression is complex and involves
multiple regulators that include agr, sarA homologues, or
svrA [32-35].
Molecular details that govern S. aureus extended persist-
ence are largely unknown. Metabolic alterations leading
to small colony variant (SCV) microorganisms are one
possibility that has been described [36-38]. Such S. aureus
variants were recently shown to efficiently invade
endothelial cells in vitro and display a markedly higher
content in fibronectin-binding proteins than the parental
strain [39]. SCVs display a major alteration in their ability
to produce or export exotoxins [36] and reveal extensive
changes in their global regulatory network [40]. Overall
this persistent behavior, possibly related to alteration of
regulatory networks, appears compatible with the prop-
erty of S. aureus to generate relapsing infections even years
after a first episode was apparently cured [36,41].
Several studies have examined details of cellular responses
after S. aureus internalization in either phagocytic or non-
phagocytic cells [42,43]. However, little is known about
bacterial gene expression upon cellular internalization.
Recent efforts in high throughput sequencing have con-
tributed to the elucidation of numerous bacterial
genomes. To date, eight fully annotated S. aureus genomes
are publicly available [44-49] allowing the design of DNA
microarrays to probe the bacterial transcriptome [50-54],
or to catalogue and type variation among clinical isolates
[53,55,56].
In this study, we describe an in vitro model where S. aureus
is able to persist for up to two weeks in the absence of
either cellular death or emergence of small colony vari-
ants. S. aureus gene expression changes between adherent
bacteria and those arising 2 h and 6 h after cellular inter-
nalization were compared using a custom-designed and
validated S. aureus oligoarray [53]. Profound shut-down
of gene expression was observed shortly after internaliza-
tion for bacterial metabolic functions and transport. This
period was followed by resumption of transcriptional
activity for metabolic and energy production functions
correlating with moderate bacterial multiplication. These
findings suggest that S. aureus extensively reprograms its
transcriptome to adjust to the intracellular environment.
Detailed study of these changes may help understanding
the molecular mechanisms governing establishment and
maintenance of persistent S. aureus infections and poten-
tially helpful for the design of new antibacterial drugs.
Results
Infection model and bacterial RNA isolation
We developed a model system that displayed protective
survival of S. aureus 6850 within human lung epithelial
cells A549. Control experiments were performed to exam-
ine infection parameters and determine the saturation of
internalization. Figure 1A shows bacterial internalization
as a function of the multiplicity of infection (m.o.i). The
profile describes a linear dose-response until saturation
for m.o.i higher than 286 S. aureus per cell. We next exam-
ined the intracellular survival of strain 6850 as a function
of time using the lysostaphin/gentamicin protectionBMC Genomics 2007, 8:171 http://www.biomedcentral.com/1471-2164/8/171
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assay, as shown Figure 1B. We observed substantial intra-
cellular survival during the first 24 hour post-internaliza-
tion. Notably, we observed a 3-fold increase in viable
bacteria recovered at 6 hours post internalization com-
pared with 2 hours indicating most probably that bacte-
rial replication, or completion of cell division, had
occurred. Viable bacterial counts diminished slightly in
the 6–24 h interval. A 3 log decrease in recovered bacteria
was observed in the interval from 1–4 days post-infection
indicating substantial infection clearance. Nevertheless,
viable bacteria could be recovered in this model system up
to 2 weeks post infection. Strain 6850 produces strong α-
Internalization of S. aureus 6850 by A549 cells Figure 1
Internalization of S. aureus 6850 by A549 cells. A. Dose-response of internalization assay performed by adding increasing 
number of bacteria to constant number of cells. The internalization assay was performed as described in the experimental sec-
tion. After 2 h, cells were detached with trypsin lyzed with dilute Triton X-100, and then internalized bacteria were assessed 
by count of colony forming units (cfu). B. Intracellular survival assay of S. aureus over a two-week interval. Note that at times 
after 6 hours, viable bacterial counts decreased, though viable bacteria were recovered from monolayers even 2 weeks after 
internalization. All values are mean ± standard deviation (SD) of at least three independent experiments. C. Viability tests were 
performed after 24 hours of internalization using bacterial m.o.i. of 100:1, or the presence of anti-CD95 (1 μg/ml) or etoposide 
(100 μM final concentration) as pro-apoptotic controls.BMC Genomics 2007, 8:171 http://www.biomedcentral.com/1471-2164/8/171
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toxin amounts as revealed on blood agar plates as well as
in strains recovered from the intracellular survival assay
(data not shown). We observed no emergence of SCV at
any time point in the assay. We conclude that the model
reflects both a window of bacterial survival and replica-
tion as well as persistent infection and we focused in early
time-points (2, 6 hours) for subsequent detailed study.
Microscopic observations with trypan blue revealed no
significant cytotoxicity as well as the absence of any cellu-
lar morphologic alteration during the first 14 days of co-
incubation (Figure 1B). Subsequent viability assays were
performed at a sub-saturating m.o.i. of 100:1 using strains
6850 or ATCC29213, previously described as cytotoxic in
other cell lines [27,30,31]. Control Jurkat T cells revealed
altered cellular viability in the presence of any of the two
bacterial strains or by contact with pro-apoptotic com-
pounds (Figure 1C). In contrast, a total absence of cellular
toxicity was observed in A549 cells in the presence of
either 6850 or ATCC strains. Similarly to previously pub-
lished observation [57], anti-CD95 failed also to affect
A549 viability whereas etoposide showed a significant
impact on A549 viability (Figure 1C).
Purification of bacterial RNA from intracellular bacteria
proved difficult due to significant excess of eukaryotic
material. After protocol optimizations, the extraction and
amplification procedures showed appreciable reproduci-
bility (additional file 1) with Pearson correlation value of
0.9–0.93, an important parameter in microarray experi-
ments [58,59]. Nevertheless, bacterial RNA preparations
contained detectable contaminating RNA traces from
host-cell. Absence of detectable cross-hybridization on
the microarray with cellular RNA demonstrates the high
specificity of the microarray for bacterial messengers
resulting from the design strategy (data not shown).
Analysis of gene expression changes in extracellular and 
adherent bacteria
We first performed several microarray experiments to
evaluate the impact of cell culture medium, presence of
cells, presence of cytochalasin D, and bacterial attachment
to cells, on the bacterial transcriptome expression. The
experimental design and pairwise comparisons performed
are depicted in Figure 2A. The following conditions were
tested: i) bacteria propagated in invasive medium alone,
ii) non-adherent bacteria cultivated in the presence of
cells, iii) non-adherent bacteria recovered from infections
in the presence of cytochalasin D, and iv) cell-adherent
bacteria in the presence of cytochalasin D. No significant
changes in gene regulation were recorded from all possi-
ble pair-wise comparisons. We conclude from this analy-
sis that exposure of bacteria to our experimental
parameters prior to cellular internalization does not result
in detectable alteration of bacterial transcriptome. We
then compared expression values obtained at time 0 in the
culture medium against those obtained after 2 or 6 hours
of internalization.
Analysis of intracellular bacterial gene expression changes
Previous studies performed in our laboratory indicated
that bacterial uptake by both A549 and MRC5 lung epi-
thelial cells is a rapid process (< 30 minutes) [17]. From
this result, as well as those presented in Figure 1B, we rea-
soned that 2 and 6 hour time points would reveal new
information about bacterial transcriptomic program
Schematic representation of conditions subjected to micro- array analysis and number of differentially expressed genes Figure 2
Schematic representation of conditions subjected to 
microarray analysis and number of differentially 
expressed genes. A. Similar expression profiles were 
observed for the comparisons between the reference condi-
tion and the control conditions consisting in i) mock infec-
tion (bacteria in cell culture medium) or ii) adherent bacteria 
(in the presence of cytochalasin D 1 μg/ml). On the opposite, 
an important number of genes were found differentially regu-
lated between reference condition and internalized bacteria 
after 2 or 6 h of intracellular survival. See material and meth-
ods section for details. B. Numbers of genes found differen-
tially regulated are indicated for each condition. The 
proportion of non-characterized genes annotated as genes 
with "unknown function" appears dark grey.
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required for early essential adaptation to the intracellular
environment. We therefore evaluated the transcriptome of
S. aureus after 2 and 6 h post-internalization.
Comparison of gene expression between control (time 0)
and 2 h or 6 h post-infection conditions revealed exten-
sive modifications in bacterial gene regulation. The com-
plete raw data set as imported from the array scanner as
well as the 2 h, 6 h, and functional group cluster is availa-
ble online [60].
Statistically significant changes in gene expression were
found for 1042 and 766 genes after 2 h or 6 h of infection,
respectively (including 338 and 165 hypothetical pro-
teins). After 2 h of infection, 346 genes were up-regulated
whereas 696 were down-regulated, while 169 genes were
found up-regulated and 600 genes down-regulated 6 h
post-infection (Figure 2B). The numbers of genes showing
differential expression levels only for one of the two time-
points were 89 and 362 for 2 or 6 h, respectively. Since all
tested control conditions did not result in significant
changes in gene expression, we conclude that these mas-
sive alterations in transcription profiles are triggered upon
bacterial internalization.
Clustering and functional group assignment
Differentially expressed genes were clustered by func-
tional group categories according to the COG classifica-
tion [61] (additional file 2). An additional category
consisting in documented virulence factors was added
(Table 1 and Figure 3), according to established criteria
[62]. Overall, the general trend revealed a substantial
down-regulation of genes involved in metabolic functions
(additional file 3). For example, among the 55 ORFs
encoding for ribosomal proteins, > 40 were found down-
regulated at 2 h, or 6 h. This reduction concerned also the
totality of the atp operon (atpA to atpH) responsible for
ATP synthesis and genes involved in nucleotide and
amino acid metabolism. Note however that the majority
of these genes were up-regulated between 2 and 6 hours.
Similar responses were also observed for numerous genes
involved in sugar metabolism and energy production. A
more balanced picture was observed among signal trans-
duction and transcription regulators (additional file 3).
Changes in gene expression of hypothetical reading
frames were observed to be equally distributed between
down- and up-regulated genes. Among genes that were
up-regulated, we noted a significant number of targets
involved in iron metabolism and other inorganic ions
(additional file 3) contributing to oxidative stress protec-
tion. Among the most significantly up-regulated genes, we
observed defense genes, such as sodA, ahp and also tran-
scription regulators of virulence factors (Table 1), RNAIII,
sarS (also named sarH1) and svrA (SA0323 or SAV0334
according to the annotation of S.aureus N315 and Mu50,
respectively) which are known to modulate the expression
of the agr locus [35,63]. Another category showing impor-
tant changes in gene expression was transporters (addi-
Table 1: Genes differentially expressed involved in virulence
Common Organism 2 h fold change 6 h Fold change Protein name
SA2423 clfB N315 0.17 0.19 Clumping factor
SA2291 fnbA N315 3.23 fibronectin binding proteins
SA2290 fnbB N315 3.83 fibronectin binding proteins
MW1940 hlb MW2 3.08 β-hemolysin
SAS065 hld N315 3.05 δ-hemolysin
SA2209 hlgB N315 3.12 γ-hemolysin
SA2461 icaB N315 3.75 Intercellular adhesion proteins
SA1638 lukE N315 3.06 leukotoxin LukE
SA1812 SA1812 N315 0.14 0.22 synergohymenotropic toxin precursor S. intermedius
SA0521 sdrE N315 0.20 0.29 Ser-Asp rich proteins
SA1817 sec3 N315 3.41 enterotoxin type C3
MW0759 sec4 MW2 3.60 4.76 enterotoxin C precursor protein
SA1642 seg N315 4.90 3.70 extracellular enterotoxin type G precursor
SA1816 sel N315 3.46 3.09 extracellular enterotoxin L
SA1648 seo N315 3.94 6.33 enterotoxin SeO
SA1009 set1 N315 3.73 exotoxin 1
SA0389 set13 N315 3.52 3.45 exotoxin 13
SA0390 set14 N315 3.77 3.73 exotoxin 14
MW0394 set26 MW2 4.95 exotoxin homolog [Genomic island nu Sa alpha2]
SA1011 set3 N315 5.00 4.69 exotoxin 3
SA0107 spa N315 0.15 0.10 Protein A
SA0901 sspA N315 0.14 0.11 V8 protease
SA0899 sspC N315 3.22 Staphopain
SA1819 tst N315 3.80 4.10 Toxic shock syndrome toxin-1
SA1645 yent1 N315 3.18 enterotoxin Yent1BMC Genomics 2007, 8:171 http://www.biomedcentral.com/1471-2164/8/171
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Global pattern of expression Figure 4
Global pattern of expression. Patterns of gene expres-
sion changes are shown for each of nine possible categories. 
The most abundant categories (B) were analyzed in depth 
after grouping by gene function. Numbers of genes in these 
two categories are also shown.
Changes in gene expression 2 h and 6 h after internalization  shown by functional categories Figure 3
Changes in gene expression 2 h and 6 h after internaliza-
tion shown by functional categories. Percent changes at 2 h 
(white) and 6 h (grey) was calculated by dividing the number of 
significantly changed genes by total genes at the given time point. 
Genes were assigned functional groups using annotated public 
database and metabolic pathways databases (COG). Categories 
are: E: Amino acid transport and metabolism, G: Carbohydrate 
transport and metabolism, D: Cell cycle control, cell division, 
chromosome partitioning, M: Cell wall/membrane/envelope bio-
genesis, H: Coenzyme transport and metabolism, V: Defense 
mechanisms, C: Energy production and conversion, R: General 
function prediction only, P: Inorganic ion transport and metabo-
lism, U: Intracellular trafficking, secretion, and vesicular transport 
I: Lipid transport and metabolism, F: Nucleotide transport and 
metabolism, O: Posttranslational modification, protein turnover, 
chaperones, L: Replication, recombination and repair, Q: Second-
ary metabolites biosynthesis, transport and catabolism, T: Signal 
transduction mechanisms, K: Transcription, J: Translation, ribos-
omal structure and biogenesis, and VF for virulence factor.BMC Genomics 2007, 8:171 http://www.biomedcentral.com/1471-2164/8/171
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tional file 3). More than 40 genes were found significantly
differentially regulated including transporters of iron, sug-
ars, nucleotides and amino-acids. Importantly, expression
of toxic virulence factors and α-hemolysin were found
either down-regulated, or unchanged, compared to the
control conditions (Table 1). Finally, the number of genes
involved in biosynthesis or degradation of bacterial enve-
lopes showed contrasted levels of expression after inter-
nalization as compared to extracellular control bacteria
(see Materials and Methods). Whereas cell-wall metabo-
lism enzymes (the autolysin lytM, and several amidases
lytA,  sgtA and SA1759) showed drastic up-regulation,
transpeptidase, acid techoic synthesis genes, the mur
operon and several cap genes showed massive down-regu-
lation after internalization (additional file 3).
Based on the time-points studied, two major regulation
profiles were found composed of genes showing: i) large
down-regulation after 2 h, then a slight increase at 6 h,
and ii) up-regulation at 2 h then only marginal change at
6 h. These two categories are presented in Figure 4A in the
upper-right and lower-left corners, respectively. Grouping
by functional category revealed that the first expression
profile is mainly composed of mobile elements, trans-
porters, regulators and iron metabolism (Fig. 4B). The
other categories were mainly composed of genes involved
in nutrient transport, general and nucleotide metabolism,
and ribosomal proteins, but also in DNA replication and
carbohydrate metabolism (Fig. 4B).
Analysis of gene expression changes in the interval 2 h-6 h
post-infection. To examine gene expression changes
occurring during its intracellular passage, we extracted a
list of genes that were differentially expressed (determined
by ANOVA) between times 2 h and 6 h after internaliza-
tion. A striking up-regulation of gene expression was
observed at 6 h post-infection in most functional catego-
ries, consistent with bacteria readapting their energy pro-
duction, intermediary metabolism, protein synthesis, and
nucleotide biosynthesis. This finding is consistent with
metabolic restart necessary for the observed bacterial dou-
blings in the 2–6 h time interval (Figure 1B).
qPCR validation of array data for selected genes
As an independent measure of differential gene expres-
sion, we examined the relative levels of 6 genes selected
from different functional categories by quantitative real-
time PCR showing up- or down-regulation or unchanged
level of expression. As previously established in other
studies, the absolute magnitudes of normalized signals
reflects the broader dynamic range of the qPCR method
compared to microarray measurements [53,64]. The
results are shown in Figure 5 and are correlated in terms
of up- or down-regulation with microarray determina-
tions. Notably, the data confirms the observed down-reg-
ulation of agr expression correlated with the absence of
hla transcription. Congruent changes were observed for
lytM, sarS and sodA that showed up-regulation of their
expression as previously recorded using microarrays (Fig-
ure 5).
Discussion
Recent efforts in the field of high-throughput sequencing
contributed to the public release of numerous bacterial
genomes of medical importance. This information
allowed the development of microarrays able to monitor
gene expression changes at the genome scale. We report
here the utilization of a microarray covering the whole
genome of Staphylococcus aureus to evaluate the behavior
of the bacterium upon cellular internalization, a phenom-
enon potentially contributing to bacterial protection
against host defenses, and important in the context of
chronic infections. Our overall findings are in agreement
with previous studies utilizing experimental cellular mod-
els of bacterial internalization, using either intracellular or
facultative intracellular pathogens. If the ability of S.
aureus  to persist in different in vitro models is widely
accepted, the capacity of S. aureus to escape from host-
defenses and persist intracellularly in vivo is still debated
[15]. In this respect, the call to document "the presence of
staphylococci within non-professional phagocytes at sites
of infection in clinicopathological tissues" [15] has been
recently demonstrated by Clément and colleagues, who
identified  S. aureus residing in human nasal epithelial
cells in vivo, a probable cause of recurrent rhinosinusitis
Quantitative PCR validation of microarray data Figure 5
Quantitative PCR validation of microarray data. 
Dynamic of gene expression changes is shown as fold change 
by real-time PCR (black bars), or by microarray determina-
tion (white bars), at 2 h (A) or 6 h (B) post-infection. Data 
are mean ± SD of triplicate measurements from 2 independ-
ent experiments.BMC Genomics 2007, 8:171 http://www.biomedcentral.com/1471-2164/8/171
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infection [19]. This in vivo survival capacity was further
documented in the same population and shown to consti-
tute a significant risk factor for recurrent episodes of rhi-
nosinusitis refractory to antimicrobial and surgical
therapy [65]. Similar behavior was also observed in an
experimental model of mastitis [20].
In our model, the presence of cells or the attachment of
bacteria to A549 cells (in the presence of cytochalasin)
showed limited impact on bacterial transcriptome. This
observation is in accordance with previous reports from
our group showing that no active bacterial process is
require for internalization [17]. With respect to bacterial
pathogenesis, this observation suggests that S. aureus
internalization is probably not rare as it requires only a
minimal number of bacterial factors [22]. In contrast to
other microorganisms known to invade eukaryotic cells
and rapidly divert cellular compounds and energy to
actively multiply [66], our study indicates that upon cellu-
lar internalization, S. aureus transiently shuts down most
of its metabolic functions and adopts an apparent "dor-
mant state" without extensively initiating classic starva-
tion or stress process. These profound changes in the
bacterial transcriptome affect approximately 40% of all
putative ORFs identified in the genomic sequence of the
bacterium and appear related to an extensive adaptation
to the new environment constituted by the intracellular
compartment. The majority of genes involved in energy
production (citrate and ATP cycles, pyruvate metabolism,
and oxidative phosphorylation) were drastically reduced
after 2 h internalization, Consequently, > 75% of S. aureus
ribosomal proteins showed a significant down-regulation,
which constitutes a common trait with streptococcal
exposition to endothelial cell [67], another Gram positive
pathogen able to invade non-phagocytic cells before
inducing apoptosis [68]. For these 2 pathogens, metabolic
and cellular division machineries appear strongly down-
regulated rapidly after internalization [67]. This situation
is markedly different from that observed in invasive intra-
cellular pathogens such as Salmonella  [69],  Shigella
[66,70], or Pasteurella [71], which show up-regulation of
most cellular processes upon internalization and are able
to multiply actively before disseminating to other cells
[69,70]. In our model, a significant increase in colony
forming unit counts was observed between 2 and 6 h of
intracellular persistence. This cellular multiplication par-
allels up-regulation of lytM, as well as that of numerous
amidases involved in cell-wall processing [72]. Concur-
rently, a slight up-regulation of cell-wall and techoic acid
synthesis genes was observed between these time points,
suggesting evidence of intracellular replication or comple-
tion of cell division, as observed in the context of S. aureus
phagocytosis by neutrophils [43]. This metabolic evolu-
tion was paralleled by a massive up-regulation of numer-
ous transporters. In our study, more than 40 transporters,
involved in inorganic ions, nucleotides or peptides, or
urea were found significantly up-regulated. Transporters
involved in metabolic pathways contribute to the direct
rerouting of cellular resources by the internalized bacte-
rium. Illustrative examples are the up-regulation of uhpT
(observed at 2 and 6 h internalization), allowing glucose-
6-phosphate acquisition, as observed during internaliza-
tion of other bacterial species [66,70] or during in vitro
[73] or intracellular exposition of S. aureus to acidic envi-
ronments [43]. S. aureus genome contains 7 putative iron
transporters [74] that are important mediators of bacterial
virulence. Iron transporters are typically up-regulated in
various internalized invasive pathogens [67,74,75]. In our
study, isdF, SA0567 and particularly bitC, were drastically
up-regulated in S. aureus, thus providing probably suffi-
cient amounts of iron from the intracellular medium,
whereas all genes composing the fhu operon, encoding
ferric hydroxamate assimilation proteins were down-regu-
lated, in accordance with their function of iron transport-
ers under specific environmental conditions [76].
Intracellular survival can potentially expose the bacterium
to cellular defense mechanisms such as oxygen radicals. In
our study, the number of up-regulated genes involved in
stress protection or bacterial defense revealed surprisingly
low. Except for sodA and cysM, whose products protect
bacterial cell against oxidative stress [77], a majority of
genes involved in oxidative stress response appeared
down-regulated. This finding is markedly different than
the behavior of Shigella [66], but consistent with previous
reports about S. pneumoniae [67]. Note however that
experiments performed in A549 cells failed to detect pro-
duction of reactive oxygen species upon bacterial uptake
(not shown). Internalized S. aureus appeared to solicit
protective functions but in a different context than that
requiring preservation of the cellular machinery integrity
as described by Voyish in the context of resistance to neu-
trophil phagocytosis [43]. In non-phagocytic cells, the
expression of capsule operon, Clp proteases family and
chaperones, as well as their known regulators ctsR and sigB
[78], potentially conferring survival against toxic cellular
metabolites was drastically down-regulated.
The expression of numerous bacterial virulence factors is
modulated through complex networks of regulatory mol-
ecules including two-component systems and global reg-
ulators such as agr or sar. Multiple regulatory pathways
contributed not only to the rapid adaptation of the bacte-
ria to environmental changes but also to the regulation of
toxins or cell-surface components expression during bac-
terial growth-phases [79,80]. In our system, upon contact
with cell monolayers, strain 6850 was in early exponential
phase of growth where agr activity is limited. Following
internalization and metabolic restart, general metabolic
functions appeared up-regulated in the absence of agrBMC Genomics 2007, 8:171 http://www.biomedcentral.com/1471-2164/8/171
Page 9 of 14
(page number not for citation purposes)
induction. In addition, internalized bacteria showed an
increase in expression of sarS and svrA simultaneously to
a marked down-regulation of saeRS  genes, which are
important compounds known to modulate agr expression
[35,63]. In parallel to a moderately increased expression
of RNAIII, a compound known to induce agr expression in
vitro, this regulation pattern results in the reduced expres-
sion of hla that potentially mediates apoptosis induction
in some systems [25,27,30]. This uncoupling between agr
and RNAIII expression has been previously observed in
vivo in an experimental model of endocarditis [81]. The
restricted level of hla expression suggests a different regu-
lation behavior under these experimental conditions or
the action of another unknown regulator. The latter hypo-
thesis is further supported by the results of Goerke [32],
who showed that mutation in agr and sar had no conse-
quence for hla expression in vivo. This unknown target is
probably not sigB, a regulator found drastically down-reg-
ulated upon internalization as well as the totality of
related rsb partners in our model. SigB has been recently
suggested as a potential partner involved in the persist-
ence of SCVs recovered from cystic fibrosis [82]. In our
study, we failed to detect such SCVs as S. aureus recovered
after 2 weeks of internalization yielded significant hemo-
lysis when plated on blood agar. However, this observa-
tion does not rule out the emergence of SCVs in our
model as this phenotype appears able to revert spontane-
ously [83]. These observations are directly related to the
absence of cytotoxicity on A549 cells even after two weeks
of infection, an observation common between our study
and previous work using SCVs [84].
In contrast to the behavior of internalized SCVs, Bantel
and colleagues reported 6850-evoked induction of apop-
tosis using Jurkat T cells [30], which is consistent with our
control assays confirming that strain 6850 was able of
provoking cytotoxic effects. In addition, Qazi and col-
leagues reported the induction of agr and bacterial escape
from endosomal vesicles rapidly after internalization
using S. aureus RN6390 and MAC-T [85]. On the contrary,
Kahl reported that i) rifampicin-treated bacteria failed to
induce apoptosis and that ii) Cowan I -a strain that failed
to multiply in epithelial cells- does not show appreciable
cytotoxic effects [25]. These observations are important
concerning S. aureus pathogenicity and suggest that cer-
tain combinations of host cells and bacteria can result in
different biological outcomes. Altogether, results
obtained with different models strongly suggest that the
internalization of S. aureus is a key factor in chronic infec-
tions, as intracellular survival occurs in cells showing a
long lifespan such as fibroblasts or epithelial cells. S.
aureus intracellular survival appears related to its capabil-
ity to adopt a discrete behavior instead of actively dupli-
cating.  S. aureus then benefits from natural or
programmed cell death to re-emerge and trigger another
episode of infection, leading to chronicity.
Conclusion
Internalization of S. aureus in non-phagocytic cells
explaining its resistance properties against cellular or
humoral host defenses is an attractive hypothesis relying
on its particular ability to generate chronic diseases. In our
model of cellular persistence, S. aureus strain 6850 is able
to reside intracellularly for prolonged period of time.
Microarray experiments provide a global picture of genes
possibly involved in S. aureus pathogenesis, and in partic-
ular, the capacity of the bacterium to diminish most of its
metabolic functions, despite soliciting numerous trans-
porters allowing maintenance of vital functions but limit-
ing its multiplication. Limited bacterial growth and
expression of regulators of virulence factors leads to a
finely controlled expression of cell-active toxins insuring
intracellular bacterial survival. Global bacterial responses
upon internalization appears complex but in accordance
with the capacity of the bacterium to reside intracellularly.
Finally, the study has uncovered dozens of potential tar-
gets for anti-infective therapeutics.
Methods
Bacterial strains and cell culture
A549 cells (ATCC CCL-185, human lung adenocarci-
noma) were maintained under 5% CO2 in minimal essen-
tial medium (MEM, Gibco) supplemented with 10% heat-
inactivated fetal calf serum (Gibco) and 100 U penicillin/
ml. Two days prior to infection, 6 × 106 cells were seeded
in 10 cm wells yielding weakly confluent monolayers (2 ×
107 cells/well) at the time of infection. S. aureus 6850 is
derived from multifocal osteomyelitis, is fully pigmented,
and maintains a stable virulence phenotype [86]. Over-
night cultures in Mueller-Hinton broth (MHB, BD-Difco)
were diluted with fresh media and grown to early log
phase for 3 hours. Cells were washed twice in PBS, filtered
(5 μm, Sartorius) to reduce aggregation and re-suspended
in MEM at 1 × 109 cells/ml. Jurkat T cells (kind gift of D.
Trono, Univ. of Geneva) were cultivated in RPMI (Gibco)
supplemented with 10% heat-inactivated fetal calf serum
(Gibco) and 100 U penicillin/ml.
Cell infection and control conditions
Three hours before infection, A549 cells were washed
once with MEM, then placed in 5.5 ml invasion medium
(IM) consisting of MEM enriched with 10% human albu-
min (ZLB Biopharma). Infections were initiated with a
multiplicity of infection (m.o.i. 100:1 bacteria/cells)
using bacteria in early logarithmic growth phase (OD600 =
0.2). Cultures were incubated 30 min at 37°C in 5% CO2
with 2 × 109 washed bacteria to allow adhesion and inter-
nalization. Non-adherent bacteria were collected (control
bacteria) and fixed with ice cold acetone/EtOH (1:1).BMC Genomics 2007, 8:171 http://www.biomedcentral.com/1471-2164/8/171
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Infected monolayer cells were washed twice with MEM to
remove residual non-adherent bacteria then incubated 20
min at 37°C in MEM supplemented with 4 μg/ml lys-
ostaphin. Cells were then washed twice with MEM and
placed in 20 ml MEM containing 100 μg/ml gentamicin
(defines time = 0). At 2 and 6 hours post-infection, cells
were washed twice with PBS, fixed in acetone/EtOH (1:1)
and processed for RNA extraction.
Cell viability test
Cells (1 × 106) were seeded in triplicate into culture plates
24 h prior to treatment. Bacterial infections were per-
formed as described for the standard lysostaphin/gen-
tamycin protection assay. Control experiments using anti-
CD95 ligation (1 μg/ml) or etoposide (100 μM final con-
centration) were included for cytotoxicity measurements
with trypan blue. At 24 hours post-internalization, cells
were washed and the viability of monolayers determined
using Trypan blue dye exclusion. Viability was evaluated
and expressed as a percentage of the control condition
plate. In some cases, we examined combined culture
supernatants and monolayers to detect the presence of
non-viable detached cells. No difference was noted from
viability measurements of monolayers alone.
Mock infection and cytochalasin D experiments
Fixation and RNA extractions were identical for every con-
dition as described above. Cells were pretreated 30 min-
utes prior infection with 1 μg/ml cytochalasin D (Sigma)
and also 60 minutes post-infection. Culture supernatants
were collected and non-adherent bacterial cells were har-
vested, washed twice with PBS and fixed. Cell surface-
attached bacteria were detached from A549 monolayer by
rapid trypsin incubation, harvested, washed, and fixed.
For mock infection, bacterial suspensions were prepared
in IM in the absence of A549 cells.
RNA extraction and purification
For all experiments, material (host cells or free bacteria)
were lysed in the presence of ice cold acetone:ethanol
(1:1) for 4 minutes. Cell monolayers were maintained on
ice, then scraped and centrifuged briefly at 4°C. Cellular
debris and bacterial pellets were suspended in ice cold RLT
buffer (Qiagen) and centrifuged, then washed four times
Table 2: List and characteristics of oligonucleotides used in the qPCR control experiments
Primer or Probe name Sequence (5'→3') Length A5'Dye ORF number in N315
HU SA1305
F_HU_34 CAAAGAGAAAACATGGTTACCATTATTAA 29
R_HU_135 CTCAAGCACCTCATAAGGATTATCAG 26
P_HU_83A AAAAGCCTATGGAAATTGCCCTCGCA 26 FAM
agrA SA1844
F_agrA_34 CAAAGAGAAAACATGGTTACCATTATTAA 29
R_agrA_135 CTCAAGCACCTCATAAGGATTATCAG 26
P_agrA_83A AAAAGCCTATGGAAATTGCCCTCGCA 26 FAM
sarS SA0108
F_sarS_553 CACCATAAATACCCTCAAACTGTTAGAG 28
R_sarS_638 TCATCTTCAGTTGAGCGTTCTTTT 24
P_sarS_596B AAAAGCAAGGCTATCTAA 18 FAM
lytM SA0265
F_lytM_32 CGATGGGCTTCGCTACATTT 20
R_lytM_105 ATGTGCTTGTTGGGTGTTTGTC 22
P_lytM_56A TGGCGCATCAAGCAGATGCAGC 22 FAM
sodA SA1382
F_sodA_168 TGTTGCTAATTTAGACAGTGTACCAGCTA 29
R_sodA_275 TCCCAGAATAATGAATGGTTTAAATG 26
P_sodA_198A CATCCAAACTGCTGTACGTAATAATGGCGG 30 FAM
sirA SA0111
F_sirA_151 GGGAAACCAAAGCGTGTTGT 20
R_sirA_246 TGTCCATGATTCTACAGCACCTACA 25
P_sirA_198A ATATCAAGGTGCCACTGACGTCGCTGT 27 FAM
A Taqman probes with a 3'-TAMRA quencher (Eurogentec, Seraing, Belgium).
B Minor groove binder probe with non-fluorescent quencher bound to the 3'end (Applied Biosystems). All experiments used concentrations of 200 
nM and 100 nM for primers and probes, respectively. Primers and probe for hla quantification have been published previously [87,88].BMC Genomics 2007, 8:171 http://www.biomedcentral.com/1471-2164/8/171
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in ice cold TE (10 mM Tris/HCl, 1 mM EDTA pH 8.0).
Fixed and washed bacteria were lysed in TE containing
200 μg/ml lysostaphin for 15 minutes at 37°C as previ-
ously described [87,88]. RNA was purified using RNeasy
columns (Qiagen) following the manufacturer's instruc-
tions. For each infection experiment, RNA from 6 wells
was pooled. Purified total RNA extracts were treated with
MicrobENRICH (Ambion) following the manufacturer's
instructions. RNA quality and yields were monitored
before and after enrichment using a 2100 BioAnalyzer
(Agilent) on PicoLab chip kit (Agilent).
cDNA synthesis, amplification, and fluorescent labeling
Total RNA (300 ng per condition) was converted into
cDNA by Superscript II (Invitrogen) and amplified follow-
ing a previously described method [89] yielding limited
bias and robust amplification [90]. Briefly, 20 ng of ds
cDNA was amplified using the Genomiphi kit (Amersham
Biosciences) according to the manufacturer's recommen-
dations, then labeled with Cy3-dCTP (Perkin Elmer)
using BioPrime DNA Labeling System (Invitrogen). Cy5-
dCTP (Perkin Elmer) labeled genomic DNA (0.5 mg)
pooled from S. aureus strains N315, Mu50, COL, and
MW2 was used as reference for the normalization process,
according to previous work [53,91].
S. aureus microarray and hybridization conditions
The S. aureus 60-mer oligonucleotide microarray contains
8455 oligonucleotides probes covering > 99% of genes of
4 sequenced S. aureus strains: N315, Mu50, MW2 and
COL [53]. Labeled cDNA (signal channel, Cy3) and
genomic DNA (control channel, Cy5) were mixed in 250
μL Agilent hybridization buffer and hybridized at 60°C
for 17 hours. Slides were washed, dried under nitrogen,
and scanned at 100% photomultiplier tube power for
both wavelengths (Agilent). Microarrays for all experi-
mental time-points were performed in triplicate.
Data analysis
Local background subtracted signals were calculated from
three independent experiments using Feature Extraction
software (Agilent version A6.1.1). To ensure spot quality,
features and their respective background which were not
uniform in pixel fluorescence intensity distribution in
both channels were flagged (non-uniformity outlier flag-
ging algorithm). Spots showing a genomic DNA reference
signal not significantly different from corresponding
background were also flagged (two-tailed Student's t-test
feature versus background with p < 0.05). Raw data were
imported and analyzed using GeneSpring 7.2 (Agilent).
Data were normalized using both per spot (signal channel
divided by the corresponding control channel and gener-
ation of log10 ratio) and per chip (to the 50th percentile).
Flagged spots of low quality were excluded from further
analysis. Replicates from the same test condition were
grouped and the mean calculated. Significance of normal-
ized data was determined using Welch's approximate t-
test adjusting individual P  values with the Benjamini-
Hochberg correction for false discovery rate multiple test.
Genes showing significant change in expression between
two conditions and fold change ≥ 3 were defined as differ-
entially expressed. Fold changes for the complete dataset
is available online as additional file 2.
The analysis of differential gene expression patterns in
nine possible combinations when comparing 0, 2, and 6
h was performed using the Welch conditional parametric
test and false discovery rate correction (variances assumed
unequal, p < 0.05). Genes showing fold changes > 1.5 are
shown.
Quantitative PCR
To confirm microarray results, the expression levels of hla,
sigB, agrA, sodA, sarS and lytM genes were determined by
real-time PCR analysis. Genomiphi-amplified material (1
ng) from independent experiments was assembled with
specific primers (Invitrogen) and fluorescent probes
(Table 2) designed using the PrimerExpress software
(Applied Biosystems) in specific enzymatic kit mixtures
(Eurogentec). PCR reactions were performed in a final
volume of 20 μl in a SDS7700 (Applied Biosystems). Rel-
ative expression levels were determined by comparing
cycle threshold (Ct) of each gene to the Ct value of the hu
gene for the same cDNA preparation [92].
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